Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Reznik

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
European Urology Focus|October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
Elife|March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinomaJianing Xu, Ed Reznik, Ho-Joon Lee, et al.
European Urology|September 9, 2025
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell CarcinomaLina Posada Calderon, Mark T Dawidek, Cerise Tang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Anatomical dynamics define cancer cachexia subtypes and identify systemic inflammation as a marker of lethal wastingSonia Boscenco, Venise Jan Castillon, Jamie Wang, et al.
Cancer Discovery|October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase InhibitionJames J Harding, Maeve A Lowery, Alan H Shih, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Germline <i>SDHA</i> mutations in children and adults with cancerMarianne Dubard Gault, Diana Mandelker, Deborah DeLair, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
European Urology Focus|October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Nature Cancer|February 11, 2021
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencingSara Parsa, Ana Ortega-Molina, Hsia-Yuan Ying, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
Elife|March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinomaJianing Xu, Ed Reznik, Ho-Joon Lee, et al.
European Urology|September 9, 2025
Defining the Histopathological, Clinical, and Genetic Characteristics of Familial BAP1-associated Renal Cell CarcinomaLina Posada Calderon, Mark T Dawidek, Cerise Tang, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Anatomical dynamics define cancer cachexia subtypes and identify systemic inflammation as a marker of lethal wastingSonia Boscenco, Venise Jan Castillon, Jamie Wang, et al.
Cancer Discovery|October 26, 2018
Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase InhibitionJames J Harding, Maeve A Lowery, Alan H Shih, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2018
Germline <i>SDHA</i> mutations in children and adults with cancerMarianne Dubard Gault, Diana Mandelker, Deborah DeLair, et al.
Pageof 11